Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active molecules. Its structure allows for selective protection of amine groups during peptide synthesis, making it valuable in solid-phase and solution-phase peptide coupling reactions. The fluorobenzyl moiety can enhance binding affinity in drug candidates due to its electron-withdrawing properties and improved metabolic stability. Commonly employed in medicinal chemistry for constructing complex molecules where controlled reactivity and purification are essential.